As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

When survival statistics shift this dramatically, it signals more than progress; it marks a turning point in how ...

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...